Test Price
4,800 AED✅ Home Collection Available
Deafness Gene Panel in UAE – 4,800 AED | NGS-Based Hereditary Hearing Loss Screening
Executive Summary & Core Metrics
Comprehensive NGS Panel for Hereditary Deafness
- Accuracy: 99.9% analytical sensitivity via ISO‑certified processing.
- Turnaround Time: Results in 4–6 weeks (vs. 8–12 weeks for standard panels).
- Logistics: VIP Mobile Phlebotomy & temperature‑controlled home collection available daily 8 AM–11 PM.
- Clinical Guidance: Post‑result teleconsultation offered to support result interpretation.
- Insurance: Direct coverage verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The Deafness Gene Panel is a targeted next‑generation sequencing (NGS) assay that examines >100 genes associated with hereditary hearing loss, including GJB2, SLC26A4, MYO15A, TMC1, and others. It is indicated for individuals with a family history of deafness, early‑onset sensorineural hearing loss, or couples planning a pregnancy who wish to understand their carrier status. The panel detects pathogenic variants, likely pathogenic variants, and copy‑number changes with high sensitivity and specificity.
| Feature | Our Deafness Gene Panel | Standard Genetic Screening |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity | ~85% Sensitivity (limited genes) |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger Sequencing / Targeted PCR |
| Turnaround Time | 4–6 Weeks | 8–12 Weeks |
| Genes Tested | Comprehensive panel (GJB2, SLC26A4, etc.) | 1–3 common genes |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I recognise the anxiety that genetic testing for hearing loss can bring to families. This panel provides critical insights into hereditary deafness risks, enabling early therapeutic interventions and informed reproductive decisions. I strongly encourage patients to discuss results with a certified genetic counsellor to personalise their care pathway.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory Notice
Medication & Pre‑Test Considerations
Do not discontinue any prescribed medication without consulting your physician. A valid doctor’s prescription is required for this genetic test, except in cases of surgery, pregnancy, or travel abroad. Inform your healthcare provider of any anticoagulant therapy or bleeding disorders prior to sample collection.
Exclusion Criteria & Safety Red Flags
Absolute Contraindications for Invasive Sampling (Amniocentesis / CVS)
- Active uterine infection or ruptured membranes.
- Uncorrected anticoagulant therapy.
- Untreated bleeding disorder.
- Note: For amniotic fluid or chorionic villi samples, collection must occur in a hospital setting – mobile phlebotomy is not available.
Relative Contraindications for Peripheral Blood Draw
- Severe anaemia (haemoglobin < 8 g/dL).
- Active bleeding diathesis.
- Local infection at the venipuncture site.
If heavy bleeding, severe pain, fever, or signs of infection occur after any procedure, seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What is the Deafness Gene Panel and who should consider it?
This panel uses next‑generation sequencing to analyse over 100 genes linked to hereditary hearing loss. It is recommended for individuals with a family history of deafness, early‑onset hearing loss, or couples planning a pregnancy who wish to evaluate their carrier risk.
2. How is the sample collected and does it require a doctor’s prescription?
The primary sample is a standard peripheral blood draw (available via VIP Mobile Phlebotomy at home). For prenatal diagnosis, amniotic fluid or chorionic villi sampling is performed only in a hospital setting. A doctor’s prescription is mandatory, except for surgical, pregnancy, or travel‑related cases as per DHA guidelines.
3. What is the cost and can insurance be used?
The test price is 4,800 AED. We offer direct insurance billing verification; contact us on WhatsApp at +971 54 548 8731 to check your coverage.
4. How long does it take to get results and what happens after?
Results are typically available within 4–6 weeks. Upon release, you will receive a detailed clinical report and a follow‑up teleconsultation with our genetic specialist to help interpret the findings and guide next steps.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
- Data Privacy: Compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Security: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Safety & Consent: Patient safety and informed consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Quality Management: Our laboratory holds ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139) and follows DHA standards for genetic testing.
- Facility License: Operated under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | Deafness Gene Panel (NGS Hereditary Hearing Loss Panel) |
| Price (AED) | 4,800 AED |
| Turnaround Time | 4–6 Weeks |
| Sample Type / Matrix | Peripheral blood (preferred); amniotic fluid or chorionic villi (prenatal diagnosis – hospital‑only collection) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Targeted Panel |
| ICD‑10‑CM Code | H90.3 (Bilateral sensorineural hearing loss) |
| LOINC Code | 47997‑3 (Hereditary hearing loss panel) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians